Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tudor domain-containing protein 6 (TDRD6) is a testis-specific, multi-tudor domain protein essential for male germ cell development. It is a central component of the chromatoid body, an RNA-rich organelle in spermatids, where it organizes ribonucleoprotein granules crucial for spermiogenesis[5][1]. TDRD6 supports proper chromatoid body architecture and enables the recruitment and assembly of RNA-processing enzymes and decay factors, including the nonsense-mediated mRNA decay (NMD) machinery, which regulates the stability and translation of mRNAs with long 3’ UTRs[1][3]. It participates in miRNA processing and is involved in spliceosome maturation during germ cell differentiation. TDRD6 is classified as a cancer/testis antigen, with aberrant expression observed in some cancers, and acts as an autoantigen in autoimmune polyendocrine syndrome. While not a classical therapeutic target like an enzyme or receptor, it is under investigation as a potential immunotherapy target and tumor biomarker due to its restricted expression in germ cells and certain malignancies[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tudor domain-containing protein 6 (TDRD6).